drugset / Trial / NCT04471298

A Study of Qishenyiqi Dripping Pills in Healthy Participants

NCT04471298

Phase 1 Completed 36 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindOther

Summary

This study will evaluate the safety and tolerability of Qishenyiqi Dripping Pills in healthy participants, following oral administration with multiple escalating dose of it.

Timeline

Start
2020-09-21
Primary completion
2021-01-11
Completion
2021-01-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 3.12 g Oral
Comparator Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 4.68 g Oral
Comparator Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 6.24 g Oral

Indications

No indication recorded.